PlantArcBio

Gene Discovery and Gene Editing Platforms for Crop Enhancement

Agriculture & Food Technologies
Public on TASE on Jan, 2021

Company Overview

Snapshot

Founded in May 2014 by Dror Shalitin, PlantArcBio operates with 11–50 employees. The company has raised $11.15M across multiple funding rounds and became public on TASE in January 2021. In February 2026, PlantArcBio announced a licensing collaboration with Helix Sementes e Biotecnologia to advance high-yield, drought-resilient corn in South America.

Business overview

PlantArcBio specializes in gene discovery and RNA interference (RNAi) technologies for agriculture. The company's proprietary DIP™ (Direct-In-Plant) and DIPPER™ platforms are used to identify and develop novel genes and gene-editing targets that enhance crop traits such as yield, drought tolerance, nutrition, and resistance to herbicides and pests. PlantArcBio also develops RNAi-based biological products as sustainable alternatives to chemical crop protection, serving the global agriculture and food technologies market by improving plant resilience and productivity for climate-adaptive farming.

Strategic signal

PlantArcBio's recent patent approvals in the US and South Korea for its DIPPER™ platform in September 2025 signify a critical validation of its gene-editing optimization technology. This expansion of intellectual property strengthens the company's competitive position in the global ag-biotech market, indicating robust progress in developing advanced tools for crop enhancement and potentially opening new avenues for commercial partnerships and market penetration.

Company Intelligence Q&A

What significant collaboration did PlantArcBio announce in February 2026?
In February 2026, PlantArcBio announced a licensing collaboration with Helix Sementes e Biotecnologia, a company within the Agroceres Group, to advance high-yield, drought-resilient corn in South America.
Which patents did PlantArcBio secure in September 2025?
In September 2025, PlantArcBio secured patents in the United States and South Korea for its proprietary DIPPER™ platform, which is designed to optimize gene-editing in crops.
What strategic collaboration did PlantArcBio forge in December 2024?
In December 2024, PlantArcBio forged a strategic collaboration with ToolGen to develop gene-edited, herbicide-tolerant soybeans for global markets.
When did PlantArcBio receive USDA-APHIS approval for its PPO herbicide-tolerant gene?
PlantArcBio received USDA-APHIS approval in the US for planting and breeding soybean modified with its novel PPO herbicide-tolerant gene in January 2024.
What patent did PlantArcBio secure in November 2023?
In November 2023, PlantArcBio secured a patent from the European Patent Office for its innovative DIP™ platform, aimed at advancing global food security.